These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1633303)

  • 1. Construction and expression of high efficiency expressing plasmid of transforming growth factor alpha-Pseudomonas aeruginosa exotoxin fusion protein TGF alpha-PE40.
    Xu Y; Shen M; Zhao Q; Zhang H; Xu Y
    Chin J Biotechnol; 1994; 10(4):233-9. PubMed ID: 7780019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
    Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
    Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of chimeric toxins.
    FitzGerald D; Chaudhary VK; Kreitman RJ; Siegall CB; Pastan I
    Targeted Diagn Ther; 1992; 7():447-62. PubMed ID: 1633306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
    Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of scale-down techniques for investigation of recombinant Escherichia coli fermentations: acid metabolites in shake flasks and stirred bioreactors.
    Dahlgren ME; Powell AL; Greasham RL; George HA
    Biotechnol Prog; 1993; 9(6):580-6. PubMed ID: 7764346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyionic and cysteine-containing fusion peptides as versatile protein tags.
    Lilie H; Richter S; Bergelt S; Frost S; Gehle F
    Biol Chem; 2013 Aug; 394(8):995-1004. PubMed ID: 23629522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and prokaryotic expression of a recombinant immunotoxin fused with mouse interleukin 18 and truncated Pseudomonas exotoxin].
    Li H; Li MY; Jiang ZH; Lü ML; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):753-6. PubMed ID: 15573745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solution structure of heregulin-alpha and a N-terminal mutant with suppressed activity.
    Adler M; Thompson SA
    Biochem Biophys Res Commun; 1999 Mar; 256(1):156-61. PubMed ID: 10066440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tab2, a novel recombinant polypeptide tag offering sensitive and specific protein detection and reliable affinity purification.
    Crusius K; Finster S; McClary J; Xia W; Larsen B; Schneider D; Lu HT; Biancalana S; Xuan JA; Newton A; Allen D; Bringmann P; Cobb RR
    Gene; 2006 Oct; 380(2):111-9. PubMed ID: 16879932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant expression and purification of a tumor-targeted toxin in Bacillus anthracis.
    Bachran C; Abdelazim S; Fattah RJ; Liu S; Leppla SH
    Biochem Biophys Res Commun; 2013 Jan; 430(1):150-5. PubMed ID: 23200832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin.
    Chaudhary VK; Queen C; Junghans RP; Waldmann TA; FitzGerald DJ; Pastan I
    Nature; 1989 Jun; 339(6223):394-7. PubMed ID: 2498664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary study of recombinant immunotoxin IL-18-PE38 in treating rheumatoid arthritis].
    Wu X; Yang C; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Apr; 19(4):306-9. PubMed ID: 15921325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
    Williams MD; Rostovtsev A; Narla RK; Uckun FM
    Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction, expression and bioactivity characterization of targeting toxin DT-VEGF].
    Chai YS; Cheng X; Yao LH; Chen AJ; Yu H; Yan XR; Jia RQ; Huang GJ; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):192-6. PubMed ID: 15969107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.
    Deonarain MP; Epenetos AA
    Br J Cancer; 1998 Feb; 77(4):537-46. PubMed ID: 9484808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor.
    Fominaya J; Uherek C; Wels W
    Gene Ther; 1998 Apr; 5(4):521-30. PubMed ID: 9614577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor immunotoxin secretion by T cells: ABSolutely FABulous?
    Fitzgerald DJ
    Nat Biotechnol; 1997 Jan; 15(1):18-9. PubMed ID: 9035099
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of growth factor-toxin fusion proteins.
    Edwards GM; Defeo-Jones D; Stirdivant SM; Heimbrook DC; Oliff A
    Targeted Diagn Ther; 1992; 7():425-37. PubMed ID: 1633303
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.